2,582 research outputs found

    Pharmacokinetics of Tacrolimus in Kidney Transplant Recipients: Twice Daily Versus Once Daily Dosing

    Full text link
    Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/72008/1/j.1600-6143.2004.00383.x.pd

    Measurement of D-meson production at mid-rapidity in pp collisions at √s=7 TeV

    Get PDF
    The production cross sections for prompt charmed mesons D0, D+, D∗+ and D+s were measured at mid-rapidity in proton–proton collisions at a centre-of-mass energy √s=7 TeV with the ALICE detector at the Large Hadron Collider (LHC). D mesons were reconstructed from their decays D0→K−π+, D+→K−π+π+, D∗+→D0π+, D+s→ϕπ+→K−K+π+, and their charge conjugates.With respect to previous measurements in the same rapidity region, the coverage in transverse momentum (pT) is extended and the uncertainties are reduced by a factor of about two. The accuracy on the estimated total ccbar production cross section is likewise improved. The measured pT-differential cross sections are compared with the results of three perturbative QCD calculations.<br/

    Use of low-dose oral theophylline as an adjunct to inhaled corticosteroids in preventing exacerbations of chronic obstructive pulmonary disease: study protocol for a randomised controlled trial.

    Get PDF
    BACKGROUND: Chronic obstructive pulmonary disease (COPD) is associated with high morbidity, mortality, and health-care costs. An incomplete response to the anti-inflammatory effects of inhaled corticosteroids is present in COPD. Preclinical work indicates that 'low dose' theophylline improves steroid responsiveness. The Theophylline With Inhaled Corticosteroids (TWICS) trial investigates whether the addition of 'low dose' theophylline to inhaled corticosteroids has clinical and cost-effective benefits in COPD. METHOD/DESIGN: TWICS is a randomised double-blind placebo-controlled trial conducted in primary and secondary care sites in the UK. The inclusion criteria are the following: an established predominant respiratory diagnosis of COPD (post-bronchodilator forced expiratory volume in first second/forced vital capacity [FEV1/FVC] of less than 0.7), age of at least 40 years, smoking history of at least 10 pack-years, current inhaled corticosteroid use, and history of at least two exacerbations requiring treatment with antibiotics or oral corticosteroids in the previous year. A computerised randomisation system will stratify 1424 participants by region and recruitment setting (primary and secondary) and then randomly assign with equal probability to intervention or control arms. Participants will receive either 'low dose' theophylline (Uniphyllin MR 200 mg tablets) or placebo for 52 weeks. Dosing is based on pharmacokinetic modelling to achieve a steady-state serum theophylline of 1-5 mg/l. A dose of theophylline MR 200 mg once daily (or placebo once daily) will be taken by participants who do not smoke or participants who smoke but have an ideal body weight (IBW) of not more than 60 kg. A dose of theophylline MR 200 mg twice daily (or placebo twice daily) will be taken by participants who smoke and have an IBW of more than 60 kg. Participants will be reviewed at recruitment and after 6 and 12 months. The primary outcome is the total number of participant-reported COPD exacerbations requiring oral corticosteroids or antibiotics during the 52-week treatment period. DISCUSSION: The demonstration that 'low dose' theophylline increases the efficacy of inhaled corticosteroids in COPD by reducing the incidence of exacerbations is relevant not only to patients and clinicians but also to health-care providers, both in the UK and globally. TRIAL REGISTRATION: Current Controlled Trials ISRCTN27066620 was registered on Sept. 19, 2013, and the first subject was randomly assigned on Feb. 6, 2014

    Timing in the ALICE trigger system

    Get PDF
    In this paper we discuss trigger signals synchronisation and trigger input alignment in the ALICE trigger system. The synchronisation procedure adjusts the phase of the input signals with respect to the local Bunch Crossing (BC) clock and, indirectly, with respect to the LHC bunch crossing instant. The synchronisation delays are within one clock period: 0-25 ns. The alignment assures that the trigger signals originating from the same bunch crossing reach the processor logic in the same clock cycle. It is achieved by delaying signals by an appropriate number of full clock periods. We propose a procedure which will allow us to nd alignment delays during the system con guration, and to monitor them during the data taking
    corecore